Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-03-01
1994-09-06
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514217, 540551, 540587, 540579, A61K 3155, C07D40304, C07D41304, C07D41704
Patent
active
053448286
ABSTRACT:
Novel polycyclic compounds represented by the following formula: A--(CH.sub.2).sub.n --COOR.sup.1, wherein R.sup.1 represents a hydrogen atom or a lower alkyl group; n represents an integer of from 0 to 5; and A is a group represented by the following formula: ##STR1## wherein X represents a hydrogen atom or a halogen atom; and Y represents a methylene group, an oxygen atom, or a sulfur atom, or A is a group represented by the following formula: ##STR2## and pharmacologically acceptable salts thereof are disclosed. Also disclosed are a method for preparing the same, a pharmaceutical composition comprising the same, an antiallergic agent and an agent for bronchial asthma comprising the same, and a method for treatment of an allergic disease or bronchial asthma comprising the step of administering the same.
REFERENCES:
patent: 3389139 (1968-06-01), Schmutz et al.
patent: 3546226 (1970-12-01), Schmutz et al.
patent: 3845074 (1974-10-01), Malen et al.
patent: 3928356 (1975-12-01), Umio et al.
Kaspersen et al. Recl: Journal of the Royal Netherlands Chem. Soc., 102(10), pp. 457-460, (1983).
Chemical Abstract, vol. 100, No. 34501n, (1983), Kaspersen.
Chemical Abstract, 11th Collective Index, 1982-1986 Substance Index.
Stedman's Medical Dictionary, 24th Edition, (Publ. by Williams & Wilkins), p. 133, (1982).
Martin et al., "The Pharmacological Properties of a New, Orally Active Antianaphylactic Compound: Ketotifen, a Benzocycloheptathiophene", Arzneim.-Forsch./Drug Res., 28, (1978); (Experiment 2.2.6.), pp. 770-782.
Folia Pharmacol., Japan, 80, (1982), pp. 251-260, Ohmori et al.
"Disodium Cromoglycate (FPL 670) (`Intal`): a Specific Inhibitor of Reaginic Antibody-Antigen Mechanisms", Nature, 216, (1967), pp. 1328-1329, Cox.
Howell et al., "A Double-Blind Trial of Disodium Cromoglycate in the Treatment of Allergic Bronchial Asthma", The Lancet, 9, (1967), pp. 539-542.
"Ketotifen", Drugs of the Future, 11, (1977), pp. 108-111, Castaner et al.
Partial European Search Report and Annex to the European Search Report on Patent Appln. EP 91-10-3059, (1991).
"The Merck Index", Encyclopedia of Chemicals, Drugs, and Biologicals, 11th Ed., (1989), pp. 91, 377, 971, and 1138, Rahway, N.J.
Ito Yasuo
Kato Hideo
Koshinaka Eiichi
Morikawa Kouji
Ogawa Nobuo
Datlow Philip I.
Hokuriku Pharmaceutical Co., Ltd.
Shah Mukund J.
LandOfFree
Piperazinealkanoic acid and a pharmaceutical composition compris does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinealkanoic acid and a pharmaceutical composition compris, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinealkanoic acid and a pharmaceutical composition compris will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1329606